Jagjit S Ahluwalia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jagjit S Ahluwalia has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
J L Brain
Department of Paediatric Surgery, Addenbrooke's Hospital, Cambridge, UK
2 shared publications- Kathryn Beardsall
Department of Paediatrics, University of Cambridge, Cambridge, UK
2 shared publications M J Murray
Departments of Neonatology and
2 shared publicationsA. L. Ogilvy-Stuart
Addenbrookes Hospital NHS Foundation Trust, Cambridge, UK
1 shared publicationA.E. Curley
Regional Neonatal Unit, Royal Maternity Hospital, Belfast, U.K.
1 shared publication- Amanda L. Ogilvy-Stuart
Neonatal Unit, Rosie Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, UK
1 shared publication
Latest Publications
- Open Access
- 18 January 2013
- Published by Springer Nature
Optimising arterial carbon dioxide during initial stabilisation in ventilated newborn infants: a randomised controlled trial
- 18 January 2013
- Published by Springer Nature
Open AccessOptimising arterial carbon dioxide during initial stabilisation in ventilated newborn infants: a randomised controlled trial
- Open Access
- 1 January 2012
- Published by Springer Nature in Molecular Autism
- Vol. 3 (1) , 17
Prenatal versus postnatal sex steroid hormone effects on autistic traits in children at 18 to 24 months of age
Studies of prenatal exposure to sex steroid hormones predict autistic traits in children at 18 to 24 and at 96 months of age. However, it is not known whether postnatal exposure to these hormones has a similar effect. This study compares prenatal and postnatal sex steroid hormone levels in relation to autistic traits in 18 to 24-month-old children.
- 1 January 2012
- Published by Springer Nature in Molecular Autism
- Vol. 3 (1) , 17
Open AccessPrenatal versus postnatal sex steroid hormone effects on autistic traits in children at 18 to 24 months of age
Studies of prenatal exposure to sex steroid hormones predict autistic traits in children at 18 to 24 and at 96 months of age. However, it is not known whether postnatal exposure to these hormones has a similar effect. This study compares prenatal and postnatal sex steroid hormone levels in relation to autistic traits in 18 to 24-month-old children.
- 1 June 2011
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 96 (Supplement) , Fa37
Validation of the continuous glucose monitoring sensor in preterm infants
Objective There is limited data on the use of continuous glucose monitoring in the preterm infant, particularly at extremes of glucose levels and over prolonged periods. This study aimed to assess the accuracy of the continuous glucose monitoring sensor (CGMS) across the glucose profile, and to determine whether there was any deterioration in accuracy over a 7 day period. Design Prospectively collected CGMS data from the Neonatal Insulin Replacement Therapy in Europe (NIRTURE) Trial were compared with data obtained simultaneously using point of care glucose monitors. Setting An international multicentre randomised controlled trial. Patients One hundred and eighty eight very low birth weight control infants. Outcome measures Optimal accuracy, Performance goals, Bland Altman and Error Grid analyses as well as accuracy. Results CGMS data were found to correlate well with point of care devices for measuring glucose levels (r=0.94), with minimal bias, mean difference (95% CI) −0.02 (−1.6 to 1.7), and met the established criteria on error grid analyses. There was no deterioration in performance over time from insertion. However accuracy of individual readings to detect hypoglycaemia, or hyperglycaemia was poor. Conclusions This data highlights that the clinical use of CGMS devices is in providing trends in glucose levels to guide in clinical management, but they can not be relied upon for diagnosing hypoglycaemia or hyperglycaemia on a single reading.
- 1 June 2011
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 96 (Supplement) , Fa37
Validation of the continuous glucose monitoring sensor in preterm infants
Objective There is limited data on the use of continuous glucose monitoring in the preterm infant, particularly at extremes of glucose levels and over prolonged periods. This study aimed to assess the accuracy of the continuous glucose monitoring sensor (CGMS) across the glucose profile, and to determine whether there was any deterioration in accuracy over a 7 day period. Design Prospectively collected CGMS data from the Neonatal Insulin Replacement Therapy in Europe (NIRTURE) Trial were compared with data obtained simultaneously using point of care glucose monitors. Setting An international multicentre randomised controlled trial. Patients One hundred and eighty eight very low birth weight control infants. Outcome measures Optimal accuracy, Performance goals, Bland Altman and Error Grid analyses as well as accuracy. Results CGMS data were found to correlate well with point of care devices for measuring glucose levels (r=0.94), with minimal bias, mean difference (95% CI) −0.02 (−1.6 to 1.7), and met the established criteria on error grid analyses. There was no deterioration in performance over time from insertion. However accuracy of individual readings to detect hypoglycaemia, or hyperglycaemia was poor. Conclusions This data highlights that the clinical use of CGMS devices is in providing trends in glucose levels to guide in clinical management, but they can not be relied upon for diagnosing hypoglycaemia or hyperglycaemia on a single reading.
- 1 September 2008
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 93 (5) , F332-F335
Decisions for life made in the perinatal period: who decides and on which standards?
Though some such as Michael Tooley3 or Peter Singer4 might argue that newborns lack consciousness and thus have no interests or independent rights, the Nuffield Council’s report makes clear its position that neonates are fully human persons and are to be treated the same as any other patient—on the basis of their best interests. The implication is that although parents may (and indeed should) continue to be involved in decision making for their child, they do not have the sole right to demand or to refuse medical interventions for their infant. As the court put it in Re J (A Minor), the power of parents to make decisions is limited to the power to make decisions in the best interests of the baby.5
- 1 September 2008
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 93 (5) , F332-F335
Decisions for life made in the perinatal period: who decides and on which standards?
Though some such as Michael Tooley3 or Peter Singer4 might argue that newborns lack consciousness and thus have no interests or independent rights, the Nuffield Council’s report makes clear its position that neonates are fully human persons and are to be treated the same as any other patient—on the basis of their best interests. The implication is that although parents may (and indeed should) continue to be involved in decision making for their child, they do not have the sole right to demand or to refuse medical interventions for their infant. As the court put it in Re J (A Minor), the power of parents to make decisions is limited to the power to make decisions in the best interests of the baby.5
- Open Access
- 10 August 2007
- Published by Springer Nature in BMC Pediatrics
- Vol. 7 (1) , 29
A randomised controlled trial of early insulin therapy in very low birth weight infants, "NIRTURE" (neonatal insulin replacement therapy in Europe)
Studies in adult intensive care have highlighted the importance of insulin and improved glucose control on survival, with 32% reduction in mortality, 22% reduction in intensive care stay and halving of the incidence of bacteraemia. Very low birth weight infants requiring intensive care also have relative insulin deficiency often leading to hyperglycaemia during the first week of life. The physiological influences on insulin secretion and sensitivity, and the potential importance of glucose control at this time are not well established. However there is increasing evidence that the early postnatal period is critical for pancreatic development. At this time a complex set of signals appears to influence pancreatic development and β cell survival. This has implications both in terms of acute glucose control but also relative insulin deficiency is likely to play a role in poor postnatal growth, which has been associated with later motor and cognitive impairment, and fewer β cells are linked to risk of type 2 diabetes later in life.
- 10 August 2007
- Published by Springer Nature in BMC Pediatrics
- Vol. 7 (1) , 29
Open AccessA randomised controlled trial of early insulin therapy in very low birth weight infants, "NIRTURE" (neonatal insulin replacement therapy in Europe)
Studies in adult intensive care have highlighted the importance of insulin and improved glucose control on survival, with 32% reduction in mortality, 22% reduction in intensive care stay and halving of the incidence of bacteraemia. Very low birth weight infants requiring intensive care also have relative insulin deficiency often leading to hyperglycaemia during the first week of life. The physiological influences on insulin secretion and sensitivity, and the potential importance of glucose control at this time are not well established. However there is increasing evidence that the early postnatal period is critical for pancreatic development. At this time a complex set of signals appears to influence pancreatic development and β cell survival. This has implications both in terms of acute glucose control but also relative insulin deficiency is likely to play a role in poor postnatal growth, which has been associated with later motor and cognitive impairment, and fewer β cells are linked to risk of type 2 diabetes later in life.
- 31 July 2006
- Published by Elsevier in Early Human Development
- Vol. 82 (7) , 477-483
A dose response study of inhaled nitric oxide in hypoxic respiratory failure in preterm infants
- 31 July 2006
- Published by Elsevier in Early Human Development
- Vol. 82 (7) , 477-483
A dose response study of inhaled nitric oxide in hypoxic respiratory failure in preterm infants
- 1 July 2005
- Published by SAGE Publications in Journal of the Royal Society of Medicine
- Vol. 98 (7) , 319-320
Neonatal pleural effusion and insertion of intercostal drain into the liver
- 1 July 2005
- Published by SAGE Publications in Journal of the Royal Society of Medicine
- Vol. 98 (7) , 319-320
Neonatal pleural effusion and insertion of intercostal drain into the liver
- Open Access
- 1 July 2005
- Published by SAGE Publications in Journal of the Royal Society of Medicine
- Vol. 98 (7) , 319-320
Neonatal Pleural Effusion and Insertion of Intercostal Drain into the Liver
- 1 July 2005
- Published by SAGE Publications in Journal of the Royal Society of Medicine
- Vol. 98 (7) , 319-320
Open AccessNeonatal Pleural Effusion and Insertion of Intercostal Drain into the Liver
- 1 February 2005
- Published by Elsevier in Seminars in Fetal and Neonatal Medicine
- Vol. 10 (1) , 31-37
Critical incident reporting systems
- 1 February 2005
- Published by Elsevier in Seminars in Fetal and Neonatal Medicine
- Vol. 10 (1) , 31-37
Critical incident reporting systems
- 29 March 2001
- Published by SAGE Publications in Journal of Intensive Care Medicine
- Vol. 16 (2) , 88-99
Bedside Graphical Display of Lung Mechanics: A Clinical Experience of Use in the NICU
- 29 March 2001
- Published by SAGE Publications in Journal of Intensive Care Medicine
- Vol. 16 (2) , 88-99
Bedside Graphical Display of Lung Mechanics: A Clinical Experience of Use in the NICU